A PHASE 2 OPEN LABEL PARTIALLY RANDOMIZED TRIAL TO EVALUATE THE EFFICACY, SAFETY AND TOLERABILITY OF COMBINATIONS OF BEDAQUILINE, MOXIFLOXACIN, PA-824 AND PYRAZINAMIDE IN ADULT SUBJECTS WITH DRUG-SENSITIVE OR MULTI DRUG-RESISTANT PULMONARY TUBERCULOSIS.: